You are here

ALPPS vs. Two-Stage Hepatectomy RCT

Welcome to the "ALPPS vs. TSH for CRLM" - RCT Platform!

Associating Liver Partition with Portal vein ligation for Staged hepatectomy (ALPPS) versus Two-Stage Hepatectomy (TSH) for marginally resectable colorectal liver metastases – a multicentric, randomized controlled trial.

Short title: "ALPPS vs. TSH for CRLM" - RCT
Clinicaltrials.gov: NCT02758977
SNCTP: TBA (Register of clinical trials in Switzerland)
KEK-ZH Nr.: 2015-0024 (Local swiss ethics committee/IRB number)

 

Sponsor-Investigator/Principal Investigator:

Prof. Pierre-Alain Clavien, MD, PhD, FACS
Director
Department of Visceral and Transplantation Surgery
University Hospital Zurich
Raemistrasse 100
CH-8091 Zurich
Switzerland
Phone: +41 (0)44 255 33 00
Fax: +41 (0)44 255 44 49

 

This multi-institutional trial is open to all centers participating in the registry who have included a minimum of 5 cases.

Further information is provided under the following links. 

Please use the contact forms if you should have any further questions or are interested in participation.

 

------------------------------------------------------------------------------------------------------

Newsfeed:

Zurich, the 17th April 2016

The department of visceral- & transplantation surgery at the university hospital of Zurich is glad to announce, that approval of the local Cantonal Ethics Committee (KEK) / Institutional Review Board (IRB) was finally obtaind in February 2016 for our "ALPPS vs. TSH for CRLM" - RCT.

Preparations for the start of the study are currently under way, patient inclusion in our department starts from 1st of May 2016.

------------------------------------------------------------------------------------------------------

 

 

Headquarters

University Hospital Zurich
Department of Surgery
Raemistrasse 100
8091 Zurich, Switzerland

Contacts

Phone: +41 (0)44 255 33 00
Fax:     +41 (0)44 255 44 49
Email: 
ALPPS@usz.ch